Educational·10 cases total

Drug Disaster History── Reading world drug disasters through the lens of regulation and lessons learned.

Drug disasters are not just "failures" ── they are the events that shaped the medicines regulation we have today. Which incident changed what? Ordered from international classics → Japan's drug disaster history → modern scandals, so that you can reverse-engineer "why the industry looks the way it does today" from the source events. Each item will be published on this page once it has passed verification.

International classics — events that built modern regulation

Elixir Sulfanilamide incident1937 / USA

Over 100 deaths from a syrup using diethylene glycol as solvent. Triggered the Federal Food, Drug, and Cosmetic Act (FDCA, 1938) — the starting point of modern drug regulation.

Thalidomide incident1957–1962 / Worldwide

Sold in 46 countries as a sleeping aid and morning sickness remedy, causing limb malformation (phocomelia) in roughly 10,000 fetuses. The disaster that built modern drug regulation — leading to the 1962 Kefauver-Harris Amendment in the U.S. and Japan's 1979 Pharmaceutical Affairs Act overhaul.

DES (Diethylstilbestrol) incident1940s–1971 / USA & others

A synthetic estrogen prescribed to prevent miscarriage. Years later, daughters exposed in utero were found to develop rare clear-cell adenocarcinoma of the vagina. Forced society to confront the concept of transgenerational toxicity.

Japan's drug disaster history

SMON incident1955–1970s / Japan

Subacute myelo-optico-neuropathy caused by the intestinal drug clioquinol. ~11,000 victims. The origin of Japan's drug administration and post-marketing surveillance (PMS) framework.

HIV-tainted blood-product incident1980s / Japan

~1,800 hemophilia patients infected with HIV from non-heat-treated coagulation factor products. Government, industry, and physician inaction were all questioned — one of the largest social shocks in Japan's drug disaster history.

Hepatitis C blood-product incident1980s–2000s / Japan

Hepatitis C virus transmitted through fibrinogen and other products used in childbirth-related hemostasis. Victims estimated at ~10,000. Led to a victim-relief law (2008) and stricter biological-product regulation.

Creutzfeldt–Jakob disease (cadaveric dura mater)1980s–1990s / Japan

CJD transmitted via human dried dura mater (Lyodura) used in neurosurgery. Japan recorded the world's largest case count — the starting point of infectious-disease risk management for biological products.

Iressa (gefitinib) incident2002– / Japan

A lung-cancer targeted drug approved as a low-toxicity "miracle drug." Fatal interstitial pneumonia followed, leading to stronger Early Post-marketing Phase Vigilance (EPPV). The courts ultimately did not find the state or company liable.

Modern drug disasters & scandals

Vioxx (rofecoxib) incident1999–2004 / USA

A COX-2 selective inhibitor. A delayed disclosure of data showing cardiovascular risk reportedly contributed to tens of thousands of myocardial infarction deaths worldwide. A symbolic case for corporate data-disclosure ethics.

Opioid crisis1996– / USA

Marketing that "addiction risk is low" for opioids such as Purdue Pharma's OxyContin drove mass prescribing; over 80,000 opioid-related deaths a year in the US, hundreds of thousands cumulatively. A structural failure still in question today.

— Each topic will be published on this page once it has passed verification —

← Back to home